Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 5Active not recruiting 2Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 13Gastrointestinal 6Lymphoid 5Gynecologic 5Other hematologic neoplasm 4Genitourinary 4Thoracic 3Tumor-Agnostic 2Other neoplasm 2Other 2Dermatologic 2Plasma cell 1

Conditions

Uveal Melanoma 1Melanoma 1

Interventions

pembrolizumab 70Nivolumab 47Ipilimumab 27Specimen Handling 15Magnetic Resonance Spectroscopy 15trametinib 14Biopsy 13dabrafenib 11cemiplimab 11avelumab 11Cyclophosphamide 11binimetinib 10Radiotherapy 9CTLA-4 Antigen 9fludarabine 8encorafenib 7atezolizumab 7Radiosurgery 7Immunoglobulin G 7Disulfides 7Cisplatin 7fludarabine phosphate 6durvalumab 6tislelizumab 5relatlimab 5lenvatinib 5dostarlimab 5Pemetrexed 5Paclitaxel 5Introns 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Methods × Dermatologic × Clear all
NCT04611568 2026-05-22

War on Melanomaâ„¢ Public Health & Education Campaign

OHSU Knight Cancer Institute

Phase NA Active not recruiting
75,000 enrolled
Dermatologic

Melanoma

NCT06075589 2026-03-19

Psychoeducation for Uveal Melanoma

Jonsson Comprehensive Cancer Center

Phase NA Active not recruiting
108 enrolled
Dermatologic

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡